Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 1,051–1,075 of 27,380 studies, newest first · page 43 of 1096.

June 2026 25

  1. 2026-06-29

    Arc mediates intercellular tau transmission via extracellular vesicles

    ✓ Peer-reviewed Laboratory science Cell

    Key finding: These results show that Arc is critical for the packaging of tau in EVs, which plays a significant role in intercellular tau transmission.

  2. 2026-06-28
  3. 2026-06-28

    Lecanemab use for early Alzheimer disease in Canada

    ✓ Peer-reviewed Treatments Canadian Medical Association Journal

    Key finding: Lecanemab is a humanized monoclonal antibody that binds soluble brain amyloid-β protein, promoting its removal and slowing the underlying process of Alzheimer disease. 1 This mechanism aligns with the amyloid hypothesis, a debated model of Alzheimer disease pathogenesis.1 Only patients with mild cog

  4. 2026-06-27

    Structured patient and public involvement programme development in low- and middle-income country health research: a scoping review of evidence gaps and a framework for future practice

    ✓ Peer-reviewed Health systems and care delivery Research involvement and engagement

    Key finding: This multisite initiative demonstrated that structured PPI is feasible in LMICs when supported by cultural adaptation, PPI coordinator roles, and tailored training for contributors and researchers.

  5. 2026-06-27
  6. 2026-06-27

    Heterogeneous responses to risk-adjustment reform: evidence from dementia diagnosis in Medicare Advantage

    ✓ Peer-reviewed Health systems and care delivery Health Affairs Scholar

    Key finding: Incident dementia diagnoses increased in MA relative to traditional Medicare, despite an overall downward trend in diagnosis rates. +4 more findings

  7. 2026-06-25

    Digitized and AI-Assisted Scoring of Cognitive Assessments in ALS and Neurodegenerative Diseases: A Scoping Review of Consistency, Reliability, and Cross-Site Applicability

    ⚠ Preprint — not yet peer-reviewed Cognitive tests and assessment PsyArXiv

    Key finding: The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) is the most validated and widely-used ALS-specific cognitive assessment tool, yet paper-and-pencil manual scoring introduces inter-rater variability that can significantly limit reliability and reproducibility in multi-site clinical trials. +1 more finding

    Scored 47 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  8. 2026-06-25

    Individual-Level Traits Outweigh Neighborhood and Landscape Level Factors for Frugivorous Insect Parasites in Small Forest Patches

    ✓ Peer-reviewed Risk factors Not indexed

    Key finding: Our results suggest that in areas like upstate New York, where agricultural land uses are dominant, individual scale factors are the most influential. +2 more findings

  9. 2026-06-24

    Hierarchical-circular model of biological memory: a multilevel hypothesis for pathogenesis and allostatic integrity in Alzheimer’s disease and related dementias

    ✓ Peer-reviewed Prevention trials Frontiers in Dementia

    Key finding: The Hierarchical-Circular Model of Biological Memory offers a unifying hypothesis for Alzheimer's disease and related dementias that bridges genetic, epigenetic, physiological, neuroimmune, and interoceptive processes across the lifespan. +1 more finding

  10. 2026-06-24

    Lymphoid-like Suppressive Microglia in Alzheimer’s Disease: A New Neuroimmune Regulatory Axis?

    ✓ Peer-reviewed Risk genes beyond APOE Cells

    Key finding: Microglia are central regulators of Alzheimer's disease pathogenesis, but their roles cannot be reduced to a simple protective-versus-harmful dichotomy. +3 more findings

  11. 2026-06-24

    Cohort Profile: Kenya Life Panel Survey

    ✓ Peer-reviewed Health systems and care delivery International Journal of Epidemiology

    Key finding: Overall, 92.7% of the original cohort members participated in at least one follow-up round and 87.2% participated in at least two (balanced by deworming treatment status). +3 more findings

  12. 2026-06-24

    The cost of dementia in the United States in 2026

    ✓ Peer-reviewed Costs and economics Alzheimer's & Dementia

    Key finding: The costs of dementia fall on families, highlighting limited policy and work supports. +1 more finding

  13. 2026-06-23

    Pearls and Pitfalls of 18F-FDG PET/CT for Suspected Alzheimer's Disease in Patient with Down Syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Molecular imaging and radionuclide therapy

    Key finding: Dementia in individuals with Down syndrome (DS) is the leading cause of early-onset cognitive decline occurring before the age of 50. +2 more findings

  14. 2026-06-23

    Polygenic Risk Scores for Incident Dementia in the Multi‐Ethnic Study of Atherosclerosis

    ✓ Peer-reviewed Disparities Genetic Epidemiology

    Key finding: We found comparable associations between dementia and PRS when comparing a C+T method with only 15 SNPs and PRS derived from Bayesian models that include > 800,000 SNPs (HR 5e‐08 = 1.18, 95% CI: 1.08–1.28; HR CSx = 1.17, 95% CI: 1.07−1.27). +2 more findings

  15. 2026-06-23

    Consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementias

    ✓ Peer-reviewed Genetics Nature Genetics

    Key finding: 128,681 cases/proxy cases and 849,833 controls analyzed, largest AD/ADRD GWAS meta-analysis to date at publication +4 more findings

  16. 2026-06-22

    MinderCare: protocol for a mixed-methods evaluation of a digitally enabled dementia care service

    ⚠ Preprint — not yet peer-reviewed Health systems and care delivery medRxiv

    Key finding: Strengths and limitations of this study This study evaluates a digitally enabled remote monitoring model for people living with dementia that integrates passive in-home sensors and algorithm-derived digital biomarkers to detect clinically relevant changes such as infection risk, behavioural disturbance and physiological deterioration. +4 more findings

    Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  17. 2026-06-22

    MCH-Guard: Multimodal Machine Learning Framework for Risk Stratification of Cerebral Microhemorrhage Risk in the Alzheimer’s Disease Neuroimaging Initiative

    ⚠ Preprint — not yet peer-reviewed Treatments medRxiv

    Key finding: MCH-Guard offers a flexible clinical decision-support tool for optimizing spontaneous MCH & ARIA surveillance.

    Scored 48 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  18. 2026-06-22

    Oral GLP-1 receptor agonist promotes astrocyte-neuron lactate and lipid transfer with neuroprotective effects

    ✓ Peer-reviewed Drug development Cell metabolism

    Key finding: OHP2 primarily activates GLP-1R on astrocytes, leading to increased aerobic glycolysis and driving lactate release. +4 more findings

  19. 2026-06-22

    Bridging the diagnostic gap: Expanding dementia care navigation for timely diagnosis

    ✓ Peer-reviewed Health systems and care delivery Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Dementia care navigation (DCN) has demonstrated value in post-diagnosis settings.

  20. 2026-06-21

    Amantadine, Donepezil and Memantine Associated Arrhythmia in an Elderly Patient

    ⚠ Preprint — not yet peer-reviewed Treatments Research Square

    Key finding: 2.1 Case İnformation A 78 years old man was referred to the cardiology clinic because of mild dyspnea. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  21. 2026-06-20

    TACDAR: Tetra Alzheimer Disease Classification via Dilated Coordinate Attention Based RegNet

    ✓ Peer-reviewed Brain scans and imaging International Journal of Computational Intelligence Systems

    Key finding: Alzheimer disease (AD) destroys brain cells and the patient’s memory is lost as a result of a progressive and incurable neurodegenerative disease. +1 more finding

  22. 2026-06-19

    Dysregulation of a novel autophagosome-mitochondria contact contributes to tauopathy-related neurodegeneration by disrupting autophagy

    ✓ Peer-reviewed Disease mechanisms Autophagy

    Key finding: Here, we reveal that tauopathy synapses exhibit excessive tethering of autophagosome/autophagic vacuole (AV)-mitochondria (Mito) contacts, driven by mitochondrial bioenergetic deficit-induced hyperactivity of adenosine monophosphate-activated protein kinase (AMPK) that results in accelerated turnover of the contact release factor TBC1D15. +1 more finding

  23. 2026-06-19

    Frontotemporal dementia associated CHCHD10V57E mutation aggravates tau pathology via disrupting the CHCHD10-Rab7A-TBC1D15 complex

    ✓ Peer-reviewed Disease mechanisms Cell Death and Disease

    Key finding: Furthermore, we showed that phosphorylated tau accumulates within the endo-lysosomal system of the CHCHD10 V57E -expressing flies and mammalian cells. +2 more findings

  24. 2026-06-18

    Case Report: SIADH-Induced Hyponatremia Following Sertraline and Quetiapine Use in an Elderly Patient with Dementia: A Case Report

    ✓ Peer-reviewed Risk factors F1000Res

    Key finding: This case underscores the importance of routine sodium monitoring in elderly patients with dementia initiated on serotonergic or antipsychotic therapy. +1 more finding

  25. 2026-06-18

    Cerebrospinal fluid NPTX2/p-tau ratio as a biomarker for cognitive decline in neurodegenerative diseases

    ✓ Peer-reviewed Tau biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: The NPTX2/p-tau ratio enhanced diagnostic performance of standalone NPTX2 and p-tau, particularly for DLB and FTLDrs (area under the curve [AUC]NPTX2/p-tau = 0.78-0.79 vs. +3 more findings

Browse the library by subject, with the full score breakdown →